Related Experiment Videos
Hepatic alpha-oxidation of phytanic acid. A revised pathway
P P Van Veldhoven1, G P Mannaerts, M Casteels
1Katholieke Universiteit Leuven, Afdeling Farmakologie Herestraat, Belgium. Paul.VanVeldhoven@med.kuleuven.ac.be
Advances in Experimental Medicine and Biology
|March 10, 2000
Summary
This study reveals a revised alpha-oxidation pathway for breaking down 3-methyl-branched fatty acids, including phytanic acid. This pathway, identified in rats, is likely functional in humans for fatty acid metabolism.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Pathways
Background:
- Phytanic acid accumulation can lead to Refsum disease.
- Understanding phytanic acid breakdown is crucial for metabolic health.
- Previous models of fatty acid oxidation require refinement for branched-chain acids.
Purpose of the Study:
- To elucidate the alpha-oxidation pathway for 3-methyl-branched chain fatty acids.
- To investigate the breakdown of phytanic acid in mammalian systems.
- To propose a revised metabolic pathway functional in humans.
Main Methods:
- Utilized synthetic 3-methyl-branched chain fatty acids.
- Experiments conducted on intact and permeabilized rat hepatocytes.
- Analysis performed on rat liver homogenates and subcellular fractions.
Main Results:
- A revised alpha-oxidation pathway for 3-methyl-branched fatty acids was proposed.
- Key steps involve acyl-CoA activation, hydroxylation, and cleavage.
- Intermediates include 2-hydroxy-3-methylacyl-CoA, formyl-CoA, and a fatty aldehyde.
Conclusions:
- The proposed alpha-oxidation pathway is likely functional in humans.
- This pathway details the breakdown of phytanic acid and similar branched-chain fatty acids.
- Further research can explore therapeutic targets for related metabolic disorders.